New to GLP-1s? Start with whether it's right for you ->
GLP-1 telehealth provider you can trust: the short answer
The GLP-1 telehealth provider you can trust most right now, by our scorecard, is Sesame Care - the highest public-source composite (42/50, B+) of the cohort we have audited on a 10-axis doctor-ethical framework. Gala GLP-1 is the listed B-tier alternative (31.5/50 after the public-source refresh). We dropped Strut Health entirely after the FDA issued it a warning letter (Reference 721448, February 2026) - a categorical disqualifier no matter the score. TMates is Under Review (composite ~25/50, below our 30-point linking floor). The point of publishing the scorecard is that you can audit which GLP-1 telehealth provider you can trust against the same axes a physician would use, not take our word for it.
Where to get it
Honest take on where to source this peptide. Open the free account first; that's how we get credited even if you skip the code at checkout.
Transparent-pricing telehealth marketplace ยท Katalys
Sesame Care
Fits: You want an insurance-aware, doctor-first GLP-1 path where the medication cost is separated from the care model and the provider can discuss branded, insurance, and cash-pay options before you commit. Public-source audit: 42/50, the strongest current GLP-1 route in our cohort.
Watch: Current Sesame pricing depends on the selected care plan, medication, insurance status, and pharmacy. We still want a signup walkthrough to confirm the exact contraindication prompts by provider, so verify the full monthly total before booking.
Step 1 Open a free account at Sesame Care ->Affiliate relationships are disclosed per FTC rules. Editorial take is independent of any commercial relationship; we only recommend what we'd actually use.
The scorecard
Each axis is scored 1 to 5 the way a physician would evaluate where to send a patient. Patient-safety screening and product-quality verification carry 1.5× weight because they are the load-bearing safety signals. Provider names in the table link to the same affiliate exits as the recommendation cards.
| Axis | Weight | Sesame Care | Gala GLP-1 | TMates GLP-1 | Strut Health |
|---|---|---|---|---|---|
| Patient-safety screening | 1.5× | 4 / 5 Success by Sesame publicly describes a comprehensive intake covering medical and family history, provider review, labs if appropriate, and clinical supervision. | 3 / 5 Official FAQ says a state-licensed provider reviews health history, goals, and individual needs before treatment. Still needs signup walkthrough for contraindication depth. | Pending verification PENDING - intake walkthrough required | Pending verification PENDING - need to complete intake walkthrough to score MTC/MEN-2 screening rigor |
| Product-quality verification | 1.5× | 4 / 5 Sesame is not the pharmacy and can route brand-name GLP-1 prescriptions through patient-selected pharmacies; pharmacy and medication details still vary by path. | 2 / 5 Compounding pharmacy partner NOT publicly named; operated by AI Coaching Inc; refund policy not surfaced on qualification landing | Pending verification PENDING - pharmacy partner disclosure not yet verified | 2 / 5 Compounding pharmacy partner NOT publicly named (we asked, they cited multiple Surescripts-network pharmacies); LegitScript accreditation not visibly claimed; HIPAA by default |
| Informed consent and transparency | 1× | 4 / 5 Marketplace model surfaces brand-name + insurance path; pricing transparent before booking | 3 / 5 Official page repeatedly discloses compounded GLP-1 medications are not FDA-approved and shows brand-name Ozempic as a separate path. | Pending verification PENDING | Pending verification PENDING - intake walkthrough |
| Prescriber model | 1× | 5 / 5 Real-doctor consult (video) at $30-100 cash-pay; substantive vs ceremonial | 3 / 5 Licensed providers in all 50 states; consult may be synchronous video or asynchronous messaging depending on patient, state law, and medication. | Pending verification PENDING | Pending verification PENDING - need to verify consult model (sync vs async) |
| Continuity of care | 1× | 5 / 5 Program publicly includes unlimited provider messaging, weekly check-ins, ongoing clinical oversight, and monitoring/adjustments. | 4 / 5 Official FAQ states ongoing chat, provider guidance, side-effect support, and dose adjustments are available during treatment. | Pending verification PENDING | Pending verification PENDING |
| Conflict of interest disclosure | 1× | 4 / 5 Doctor-first model means service is not incentivized to push a specific compounded SKU | 3 / 5 Gala discloses it provides administrative, technology, and management services while medical services come from affiliated medical practices. | Pending verification PENDING | Pending verification PENDING |
| Pricing transparency and ethics | 1× | 5 / 5 Per-visit pricing visible before booking; no subscription lock-in | 3 / 5 $179/mo all-in starter is visible but dose-tier pricing above starter requires the qualification quiz - partial transparency | Pending verification PENDING - direct product pages are positive signal but pricing per-tier not yet verified | 5 / 5 Per-SKU per-dose pricing visible BEFORE sign-up; cancel without fees; refund policy 'no refund on shipped medication' is standard for telehealth pharmacy |
| State coverage | 1× | 4 / 5 Sesame shows a broad national provider marketplace and online weight-loss provider roster; exact service availability should still be checked at booking. | 4 / 5 Official page claims licensed providers in all 50 states and a nationwide pharmacy network. Still needs state-by-state fulfillment spot check. | Pending verification PENDING | 4 / 5 State-restricted in Arkansas; otherwise broad coverage; restrictions visible |
| Independent reputation | 1× | 4 / 5 Sesame publicly shows BBB accreditation and LegitScript approval signal; still worth periodic review monitoring. | 3 / 5 Official page links Trustpilot and publishes success stories; independent review depth still needs a separate reputation sweep. | Pending verification PENDING | Pending verification PENDING - Reddit + Trustpilot scan needed |
| Specialization vs shotgun | 1× | 3 / 5 Not GLP-1-specialized; broad telehealth marketplace - the doctor is specialized, not the platform | 4 / 5 GLP-1-specialized; single-product-line focus | 5 / 5 Direct deep-link product pages per molecule (Semaglutide, Tirzepatide, NAD+, Sexual Health, TRT) - the only partner offering this structure on our matrix | 4 / 5 Multiple GLP-1 SKUs + sermorelin + other longevity peptides; specialized in telehealth-Rx model |
| Weighted composite | / 50 | 42 / 50 Tier B+ | 31.5 / 50 Tier B- (provisional) | 25 / 50 Under review | Pending Skip Tier - disqualified |
Live from our 10-axis doctor-ethical framework. Source data: /data/partner-scorecard.json. If an axis still says pending, we have not finished that verification step and will not invent a number.
The audit log (proof the framework is real)
The scorecard moves both directions. We dropped our own former #1 pick on an FDA letter and publicly corrected an over-extension within 24 hours. That is the difference between a framework and a commission funnel.
2026-05-30 · Dropped · Strut Health
FDA Warning Letter 721448 (2026-02-20) cited false/misleading marketing on compounded semaglutide and tirzepatide labels. Categorical disqualifier - removed from all live placements regardless of composite score. Verified directly against the FDA warning-letter database.
2026-05-31 · Corrected · TMates
A third-party source alleged TMates marketed compounded products as 'FDA-approved.' Direct Playwright capture of tmates.com refuted it - the site actually states compounded medications 'are not evaluated by the FDA.' We removed the false disqualifier publicly. TMates still stays Under Review on a below-threshold composite and unnamed pharmacy partner. The correction is the framework working in both directions.
2026-05-30 · Promoted · Sesame Care
Promoted to primary GLP-1 partner after Strut's removal - highest audited composite, real video consult, transparent pricing, brand-name + insurance pathway surfaced honestly.
2026-07-03 · Refreshed · Sesame Care + Gala GLP-1
Refreshed both scorecards from official public source pages. Sesame now scores 42/50 on public signals; Gala now scores 31.5/50. Signup walkthrough caveats remain in notes instead of dominating the user-facing table.
Full reasoning and every prior cycle is published at how we evaluate partners.
Questions readers actually ask
What is the most trusted GLP-1 telehealth provider right now?
By our 10-axis doctor-ethical scorecard, Sesame Care is the current top pick (42/50, B+ public-source audit) because it offers a real video consult with a US-licensed provider, transparent pre-booking pricing, ongoing oversight, and a brand-name + insurance pathway instead of defaulting everyone to compounded. Gala GLP-1 (31.5/50, Tier B provisional) is the listed alternative. Trust is per-axis, not a single star rating - the scorecard shows exactly where each provider is strong and where a signup walkthrough is still needed.
Why did Protocol One drop Strut Health?
The FDA issued Strut Health a warning letter (Reference 721448, February 2026) citing false or misleading marketing on compounded semaglutide and tirzepatide product labels. A documented FDA warning letter for a partner pharmacy in the last 36 months is a categorical disqualifier in our framework - automatic Skip Tier regardless of how the rest of the scorecard looks. Strut was our previous top pick; we removed it from all live placements on 2026-05-30 and verified the letter directly against the FDA database.
How do I know your recommendation is not just the highest-commission partner?
Because the methodology is public and the scorecard contradicts us in plain sight if our picks do not match. We link the framework winner, not the commission winner, and we log every audit action - including dropping our own former #1 pick (Strut) and publicly correcting an over-extension on TMates within 24 hours. You can read every score, every reason, and every disqualifying line at /how-we-evaluate-partners.
What makes one GLP-1 telehealth provider more trustworthy than another?
We score ten axes the way a physician would weigh where to send a patient: patient-safety screening and product-quality verification (both 1.5x weight), informed-consent transparency, prescriber model, continuity of care, conflict-of-interest disclosure, pricing transparency, state coverage, independent reputation, and specialization. A GLP-1 telehealth provider you can trust names its 503A pharmacy, runs a real consult rather than a rubber-stamp, surfaces the brand-name and insurance path honestly, and prices transparently before signup. The scorecard shows exactly where each provider lands on each of those.
Is Gala GLP-1 a good alternative to Sesame Care?
Gala GLP-1 is our listed Tier B alternative (31.5/50 after the public-source refresh). It is the right pick if you want one flat all-in monthly price ($179/mo annual-plan headline) that bundles compounded medication, provider access, shipping, and support. The trade-offs we disclose: compounded medication is not FDA-approved, final pricing depends on selected plan and medication, and the specific compounding pharmacy partner is not publicly named. For most readers Sesame Care remains primary because the doctor-first consult surfaces insurance options first, but Gala is a legitimate alternative with its trade-offs on the table.
Where to go next
- Sesame vs Gala GLP-1 - the side-by-side decision page for the top two commercial paths
- Sesame Care weight loss cost - care fee plus medication, with caveats
- Gala GLP-1 cost - bundled pricing and billing-term caveats
- The full GLP-1 telehealth matrix - all the audited partners side by side
- How we evaluate partners - the 10-axis framework and the public audit log
- Should you get on a GLP-1? - the decision before the provider
- Subscribe to the dispatch
Subscribe to the dispatch
None of this replaces a doctor. Compounded GLP-1s are dispensed under the FDA 503A shortage framework, not FDA-approved. Pricing changes. Talk to a real prescriber before you start, switch, or stop anything.